Skip to content

The Background Infusion Rate of Ropivacaine 0.2% for Continuous Interscalene Brachial Plexus Block after Rotator Cuff Repair

The Background Infusion Rate of Ropivacaine 0.2% for Continuous Interscalene Brachial Plexus Block after Rotator Cuff Repair

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNC-11001351
Enrollment
Unknown
Registered
2011-05-31
Start date
2010-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tears

Interventions

1:If the previous patient had successful pain relieve with NRPS<4 during the 48 hours postoperative period, the back ground infusion rate of the next patient was reduced by 0.5ml/h. If the NRPS=4, a b
(to be continued):If the NRPS remained more than 3, the case was regarded as technical failure, then the next patient received the same dose. If the NRPS reduced, the case was regarded as having satis

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 30 ASA physical status I–III inpatients; 2. Both male and female, aged 18-75 yr; 3. Undergoing elective rotator cuff repair at the Peking University Third Hospital.

Exclusion criteria

Exclusion criteria: 1. Patient refusal of interscalene block; 2. Body mass index>=35; 3. Thromboembolism, neuropathies, contraindication for peripheral nerve block (infection at the injection site, coagulation disorders, severe anemia, for example), severe respiratory disease, chronic opioid use, mental illness.

Design outcomes

Primary

MeasureTime frame
NRPS;

Countries

China

Contacts

Public ContactMin Li
liminanesth@yahoo.com.cn+86 10 82267275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026